113 related articles for article (PubMed ID: 547729)
1. Activation of pleural macrophages by intrapleural application of Corynebacterium parvum.
Basić I; Rodé B; Kastelan A; Milas L
Adv Exp Med Biol; 1979; 121(A):333-41. PubMed ID: 547729
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant pleural effusions with intracavitary Corynebacterium parvum.
Casali A; Gionfra T; Rinaldi M; Tonachella R; Tropea F; Venturo I; De Martino C; Curcio CG
Cancer; 1988 Aug; 62(4):806-11. PubMed ID: 3293763
[TBL] [Abstract][Full Text] [Related]
3. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
Wolmark N; Fisher B
Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
[No Abstract] [Full Text] [Related]
4. Role of pulmonary macrophages in resistance to experimental metastasis.
Jackson RA; Lill PH; Gangemi JD
J Leukoc Biol; 1986 Nov; 40(5):575-87. PubMed ID: 3464675
[TBL] [Abstract][Full Text] [Related]
5. Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum.
Kirchner H; Holden HT; Herberman
J Immunol; 1975 Nov; 115(5):1212-6. PubMed ID: 1176773
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of purified cell walls from Corynebacterium parvum.
Riveros-Moreno V; Bomford R; Scott MT
J Natl Cancer Inst; 1978 Mar; 60(3):653-8. PubMed ID: 625069
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity and lymphoreticular stimulation properties of fractions isolated from Corynebacterium parvum.
Cantrell JL; Wheat RW
Cancer Res; 1979 Sep; 39(9):3554-63. PubMed ID: 225023
[No Abstract] [Full Text] [Related]
8. Effects of the Landschütz ascites carcinoma and ascitic fluid on macrophage activity in C. parvum-injected mice.
McIntosh LC; Pugh-Humphreys RG; Thomson AW
Br J Cancer; 1981 Apr; 43(4):496-504. PubMed ID: 7236491
[TBL] [Abstract][Full Text] [Related]
9. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
Lee KC; Berry D
J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
[TBL] [Abstract][Full Text] [Related]
10. Possible mechanisms underlying the induction of cytotoxic macrophages by Corynebacterium parvum: in vitro induction of cytotoxicity in normal macrophages by immune lymphocytes.
Cullen RT; Ghaffar A
J Reticuloendothel Soc; 1978 Oct; 24(4):339-49. PubMed ID: 81874
[No Abstract] [Full Text] [Related]
11. [Inhibition of growth and metastases of lung carcinoma in C57BL/6 mice by Corynebacterium parvum and its antitumor mechanism].
Xiao Y; Lu Y; Zhang J; Cao J; Huang X
Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(3):318-21. PubMed ID: 2093073
[TBL] [Abstract][Full Text] [Related]
12. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
Kiya K; Toge T; Harada K; Uozumi T; Hattori T
Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
[TBL] [Abstract][Full Text] [Related]
13. Reticulostimulating properties of killed vaccines of anaerobic coryneforms and other organisms.
Cummins CS; Linn DM
J Natl Cancer Inst; 1977 Dec; 59(6):1697-708. PubMed ID: 411938
[TBL] [Abstract][Full Text] [Related]
14. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
Haskill S; Ritter F; Becker S
J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
[No Abstract] [Full Text] [Related]
15. The adjuvant effect of Corynebacterium parvum: T-cell dependence of macrophage activation.
Sljivić VS; Watson SR
J Exp Med; 1977 Jan; 145(1):45-57. PubMed ID: 299769
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the antitumour activities of glucans and C. parvum.
Bomford R; Moreno C
Dev Biol Stand; 1977 Apr 13-15; 38():291-5. PubMed ID: 608513
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of macrophage activation by Corynebacterium parvum. I. In vitro experiments.
Christie GH; Bomford R
Cell Immunol; 1975 May; 17(1):141-9. PubMed ID: 1092470
[No Abstract] [Full Text] [Related]
18. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
19. The effect of bone marrow depletion on prostaglandin E-producing suppressor macrophages in mouse spleen.
Shibata Y; Volkman A
J Immunol; 1985 Dec; 135(6):3897-904. PubMed ID: 2933455
[TBL] [Abstract][Full Text] [Related]
20. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
